Prostanoids and Drugs

  • B. Samuelsson
  • F. Berti
  • G. C. Folco
  • G. P. Velo

Part of the NATO ASI Series book series (NSSA, volume 177)

Table of contents

  1. Front Matter
    Pages i-x
  2. Bengt Samuelsson
    Pages 1-4
  3. Robert C. Murphy, Keith L. Clay, Joseph A. Zirrolli
    Pages 5-14
  4. Francesca Catella, Jana M. Johnson, Garret A. FitzGerald
    Pages 15-22
  5. Danny O. Stene, Robert C. Murphy
    Pages 37-46
  6. Carol F. Ng, Hsioa-Yung Ho, Patrick Y.-K. Wong
    Pages 47-53
  7. Priscilla J. Piper, Marwa N. Samhoun, Dolores M. Conroy, H. B. Yaacob, N. C. Barnes, Jane M. Evans et al.
    Pages 55-64
  8. Giovanni de Gaetano, Chiara Cerletti
    Pages 65-69
  9. B. M. Peskar, E. Bacha, P. Nowak
    Pages 137-144
  10. B. M. Peskar, K. M. Müller, M. Arndt, F. Pelster
    Pages 145-151
  11. G. P. Velo, G. Cavallini, G. Brocco, P. G. Orlandi, L. Franco
    Pages 153-160
  12. A. Bennett, I. A. Tavares
    Pages 161-167
  13. Per Hedqvist, Sven-Erik Dahlén, Johan Raud, Lennart Lindbom, Åsa Thuresson-Klein, K. C. Nicolaou
    Pages 169-182
  14. A. F. Welton, P. C. Will, D. W. Morgan, H. Crowley, M. O’Donnell, J. Hurley et al.
    Pages 195-219
  15. Iván L. Bonta, Graham R. Elliott, Shlomo Ben-Efraim
    Pages 235-242
  16. Back Matter
    Pages 249-260

About these proceedings


This volume, the sixth in the series "The Prostaglandin System" assembles most of the lecture notes from the International School of Pharmacology on "Prostanoids and Drugs" that took place in Erice, Sicily, at the "Ettore Majorana Center for Scientific Culture" on Sept 5-15, 1989. The course, which was a NATO Advanced Study Institute, comprised detailed discussion of basic metabolic pathways of arachidonic acid as well as their location in the everyday practice of clinical medicine. The current status of our knowledge on drugs affecting prostanoid metabolic pathways, and/or their functinal effects, together with the use of prostanoids as drugs, has been reviewed in depth by distinguished experts. In certain instances a few chapters might overlap with others to present divergent viewpoints of authors, for a better assessment of the complexity of eicosanoid biology. It is likely that as our knowledge of prostanoids in different diseases increases, new diseases may also be targets for drugs related to these lipid mediators. We hope that this boo~will encourage basic scientists and clinicians to pursue additional biomedical investigations along these lines of inquiry. Moreover we would like to take this opportunity to express our gratitude to all the invited speakers not only for their important contributions before and during the course but also for their ability in creating an atmosphere in which all questions were legitimate and all lines of investigations were encouraged.


asthma cancer cardiovascular system chemotherapy cytokine inflammation lipide metabolism peptides research

Editors and affiliations

  • B. Samuelsson
    • 1
  • F. Berti
    • 2
  • G. C. Folco
    • 3
  • G. P. Velo
    • 4
  1. 1.Karolinska InstituteStockholmSweden
  2. 2.University of MilanMilanItaly
  3. 3.University of ParmaParmaItaly
  4. 4.University of VeronaVeronaItaly

Bibliographic information

Industry Sectors
Chemical Manufacturing
Health & Hospitals
Consumer Packaged Goods